Covered recipient · General Payments record
EMMANUEL C OKAFOR
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$4,601.60
- Reported across 192 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $760.30 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $505.56 | 18 |
| ViiV Healthcare Company | $124.99 | 1 |
| Janssen Biotech, Inc. | $42.48 | 2 |
| QOL Medical, LLC | $20.68 | 1 |
| PFIZER INC. | $17.80 | 1 |
| Celgene Corporation | $17.75 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $17.07 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.29 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105148880 | CMS |
| ABBVIE INC. | $14.11 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105148882 | CMS |
| ABBVIE INC. | $15.07 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105148884 | CMS |
| ABBVIE INC. | $12.95 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105148886 | CMS |
| ABBVIE INC. | $17.23 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105148888 | CMS |
| ABBVIE INC. | $5.78 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105148890 | CMS |
| ABBVIE INC. | $17.79 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105148892 | CMS |
| ABBVIE INC. | $14.58 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105148894 | CMS |
| ABBVIE INC. | $22.30 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105148896 | CMS |
| ABBVIE INC. | $15.80 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105148898 | CMS |
| ABBVIE INC. | $14.75 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105148900 | CMS |
| ABBVIE INC. | $124.20 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105148902 | CMS |
| ABBVIE INC. | $23.95 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105148904 | CMS |
| ABBVIE INC. | $1.11 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105148906 | CMS |
| ABBVIE INC. | $21.59 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105148908 | CMS |
| ABBVIE INC. | $22.93 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105148910 | CMS |
| ABBVIE INC. | $124.99 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105148912 | CMS |
| ABBVIE INC. | $19.14 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105148914 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $17.07 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146959995 | CMS |
| Celgene Corporation | $17.75 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101145485 | CMS |
| Janssen Biotech, Inc. | $21.50 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078511265 | CMS |
| Janssen Biotech, Inc. | $20.98 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078511280 | CMS |
| PFIZER INC. | $17.80 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131358495 | CMS |
| QOL Medical, LLC | $20.68 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147719449 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.97 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137645836 | CMS |
| ViiV Healthcare Company | $124.99 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112761430 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.